Anacor Pharmaceuticals, Inc. Insider Trading for March 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Anacor Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Anacor Pharmaceuticals, Inc. for March 2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 23 2015 | ANAC | Anacor Pharmaceuti ... | Parker Geoffrey M. | Executive Vice Pres ... | Buy | P | 52.43 | 3,000 | 157,304 | 173,000 | 170 K to 173 K (+1.76 %) |
| Mar 23 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Sell | S | 56.07 | 37,500 | 2,102,644 | 308,760 | 346.3 K to 308.8 K (-10.83 %) |
| Mar 18 2015 | ANAC | Anacor Pharmaceuti ... | Plattner Jacob j | Senior VP, Research | Sell | S | 55.60 | 8,920 | 495,952 | 35,680 | 44.6 K to 35.7 K (-20.00 %) |
| Mar 18 2015 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Option Exercise | M | 6.92 | 12,000 | 83,040 | 40,900 | |
| Mar 18 2015 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Sell | S | 56.76 | 4,100 | 232,711 | 28,156 | 32.3 K to 28.2 K (-12.71 %) |
| Mar 18 2015 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Sell | S | 56.27 | 7,900 | 444,514 | 32,256 | 40.2 K to 32.3 K (-19.67 %) |
| Mar 18 2015 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Buy | M | 6.92 | 12,000 | 83,040 | 40,156 | 28.2 K to 40.2 K (+42.62 %) |
| Mar 04 2015 | ANAC | Anacor Pharmaceuti ... | Chanda Sanjay | SVP, Drug Developme ... | Option Exercise | M | 7.55 | 48 | 362 | 13,552 | |
| Mar 04 2015 | ANAC | Anacor Pharmaceuti ... | Chanda Sanjay | SVP, Drug Developme ... | Option Exercise | M | 7.25 | 4,952 | 35,902 | 0 | |
| Mar 04 2015 | ANAC | Anacor Pharmaceuti ... | Chanda Sanjay | SVP, Drug Developme ... | Sell | S | 45.00 | 48 | 2,160 | 29,087 | 29.1 K to 29.1 K (-0.16 %) |
| Mar 04 2015 | ANAC | Anacor Pharmaceuti ... | Chanda Sanjay | SVP, Drug Developme ... | Buy | M | 7.55 | 48 | 362 | 29,135 | 29.1 K to 29.1 K (+0.17 %) |
| Mar 04 2015 | ANAC | Anacor Pharmaceuti ... | Chanda Sanjay | SVP, Drug Developme ... | Sell | S | 45.00 | 4,952 | 222,840 | 29,087 | 34 K to 29.1 K (-14.55 %) |
| Mar 04 2015 | ANAC | Anacor Pharmaceuti ... | Chanda Sanjay | SVP, Drug Developme ... | Buy | M | 7.25 | 4,952 | 35,902 | 34,039 | 29.1 K to 34 K (+17.02 %) |
| Mar 04 2015 | ANAC | Anacor Pharmaceuti ... | IPPOLITO VINCENT P | EVP & Chief Commerc ... | Sell | S | 44.34 | 1,154 | 51,174 | 70,603 | 71.8 K to 70.6 K (-1.61 %) |
| Mar 04 2015 | ANAC | Anacor Pharmaceuti ... | IPPOLITO VINCENT P | EVP & Chief Commerc ... | Sell | S | 43.81 | 7,846 | 343,763 | 71,757 | 79.6 K to 71.8 K (-9.86 %) |
| Mar 04 2015 | ANAC | Anacor Pharmaceuti ... | Plattner Jacob j | Senior VP, Research | Sell | S | 44.60 | 400 | 17,841 | 44,600 | 45 K to 44.6 K (-0.89 %) |
| Mar 04 2015 | ANAC | Anacor Pharmaceuti ... | Plattner Jacob j | Senior VP, Research | Sell | S | 43.99 | 6,475 | 284,815 | 45,000 | 51.5 K to 45 K (-12.58 %) |
| Mar 04 2015 | ANAC | Anacor Pharmaceuti ... | Maples Kirk R | SVP, Program Manage ... | Sell | S | 43.95 | 600 | 26,369 | 9,020 | 9.6 K to 9 K (-6.24 %) |